Negative correlation of L-glutamine concentration with proliferation rate in rat hepatomas

• Published in: Life sciences (1973) Vol. 34; no. 3; p. 301
• Main Authors: Sebolt, J S, Weber, G
• Format: Journal Article
• Language: English
• Published: Netherlands 16-01-1984
• Subjects: Animals; Cell Differentiation; Cell Division; Glutamate-Ammonia Ligase - metabolism; Glutamine - metabolism; Hepatectomy; Liver - cytology; Liver - enzymology; Liver - metabolism; Liver Neoplasms, Experimental - enzymology; Liver Neoplasms, Experimental - metabolism; Liver Neoplasms, Experimental - pathology; Liver Regeneration; Male; Rats; Rats, Inbred ACI; Rats, Inbred BUF; Tissue Distribution
• ISSN: 0024-3205
• DOI: 10.1016/0024-3205(84)90603-9

The concentration of L-glutamine was determined in freeze-clamped samples of normal liver of adult male fed rats (5.7-6.1 mumol/g) and in transplantable hepatomas of vastly different proliferative rates. The L-glutamine concentration in the slowly growing hepatomas was in the range of the normal liver and it decreased in relation to the increase of hepatoma growth rate, in the most rapidly growing tumors amounting to 12% of that of normal liver. In 24-hour regenerating liver, the glutamine content was slightly reduced (by 17%). In normal rat organs of high cell renewal, such as testis, intestinal mucosa, spleen, and thymus, the L-glutamine concentration was 18 to 46% of that of normal rat liver. The L-glutamine content was similar in rat brain and liver, but it was 1.6-fold higher in the heart, and low in the blood. Glutamine synthetase (EC 6.3. 1.3) activity in normal adult liver of ACI/N strain rats was 1,000 nmol per hr per mg protein; the activity increased in the very slowly growing hepatoma 20, but decreased markedly in all the other hepatomas. Thus, glutamine synthetase activity was essentially transformation-linked. The negative correlation of glutamine content with growth rate in transplanted hepatomas appears to be more closely linked with the activities of enzymes that utilize glutamine. The low L-glutamine concentration in the rapidly growing hepatomas provides a potential marker for anti-glutamine chemotherapy selectively targeted against the glutamine-utilizing enzymes.